Industry › BioTech
Press Releases
Everest Medicines Announces 2025 Interim Results: 'Dual-Engine' Strategy Driving Strong Synergies Between Commercialization and R&D
Everest Medicines Limited
Sep 01, 2025 21:55 JST
Everest Medicines Announces 2025 Interim Results: 'Dual-Engine' Strategy Driving Strong Synergies Between Commercialization and R&D
Everest Medicines Limited
Sep 01, 2025 20:55 HKT/SGT
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation
Essex Bio-Technology Limited
Aug 26, 2025 20:00 HKT/SGT
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab)
Eisai
Aug 25, 2025 18:30 HKT/SGT
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Successfully Carries Out Space Protein Crystallization Experiments
TANAKA MIRAI Lab.
Aug 22, 2025 02:00 HKT/SGT
Lepu Biopharma (2157.HK) announces 2025 interim results
Lepu Biopharma Co., Ltd.
Aug 21, 2025 14:38 HKT/SGT
樂普生物(2157.HK)公佈2025年中期業績 ADC管線多產品進入關鍵臨床階段 收入同比大增350%
Lepu Biopharma Co., Ltd.
Aug 21, 2025 14:23 HKT/SGT
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Essex Bio-Technology Limited
Aug 13, 2025 20:24 HKT/SGT
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
CanSino Biologics Inc
Aug 20, 2025 20:30 HKT/SGT
